NASDAQ: SGMOSangamo Therapeutics Revenue
Sangamo Therapeutics revenue was $63.76M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $6.4M, down 14.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SGMO annual revenue was $57.8M, with -67.2% growth year-over-year.
SGMO past revenue growth
How has SGMO's revenue growth performed historically?
Company
239.92%
Industry
1,361.15%
Market
34.96%
SGMO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SGMO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SGMO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
SGMO revenue history
Current Revenue
$63.8M
Current Earnings
-$80.7M
Current Profit Margin
-126.6%
Be the first to know when SGMO announces revenue.
SGMO Revenue History By Year
| SGMO Yearly Revenue | SGMO Revenue | SGMO Change | SGMO Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $57.80M | -$118.43M | -67.20% |
| 2023-12-31 | $176.23M | $64.93M | +58.34% |
| 2022-12-31 | $111.30M | $598.00k | +0.54% |
| 2021-12-31 | $110.70M | -$7.49M | -6.34% |
| 2020-12-31 | $118.19M | $15.76M | +15.39% |
| 2019-12-31 | $102.43M | $17.98M | +21.29% |
| 2018-12-31 | $84.45M | $47.89M | +130.95% |
| 2017-12-31 | $36.57M | $17.18M | +88.60% |
| 2016-12-31 | $19.39M | -$20.15M | -50.96% |
| 2015-12-31 | $39.54M | -$6.33M | -13.80% |
| 2014-12-31 | $45.87M | $21.74M | +90.07% |
| 2013-12-31 | $24.13M | $2.48M | +11.44% |
| 2012-12-31 | $21.66M | $11.34M | +109.86% |
| 2011-12-31 | $10.32M | -$10.49M | -50.40% |
| 2010-12-31 | $20.81M | -$1.38M | -6.23% |
| 2009-12-31 | $22.19M | $6.00M | +37.08% |
| 2008-12-31 | $16.19M | $7.09M | +77.91% |
| 2007-12-31 | $9.10M | $1.21M | +15.38% |
| 2006-12-31 | $7.89M | $5.40M | +217.43% |
| 2005-12-31 | $2.48M | $1.17M | +88.90% |
| 2004-12-31 | $1.32M | -$1.26M | -49.01% |
| 2003-12-31 | $2.58M | -$1.76M | -40.62% |
| 2002-12-31 | $4.34M | -$542.00k | -11.10% |
| 2001-12-31 | $4.89M | $1.45M | +42.30% |
| 2000-12-31 | $3.43M | $1.25M | +57.33% |
| 1999-12-31 | $2.18M | $144.00k | +7.07% |
| 1998-12-31 | $2.04M | $886.00k | +76.91% |
| 1997-12-31 | $1.15M | N/A | N/A |
Sangamo Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.